NxStage Medical, Inc.:市場シェア分析...市場調査レポートについてご紹介

【英文タイトル】NxStage Medical, Inc. Market Share Analysis

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 8
1.2 List of Figures 8
2 Introduction 9
2.1 What Is This Report About? 9
3 Definitions of Markets/Categories Covered 10
3.1 Nephrology and Urology Devices 10
3.1.1 Renal Dialysis Equipment 10
4 Company Snapshot 11
4.1 Key Facts 11
4.2 Company Overview 11
4.3 Financial Performance 11
4.4 Business Overview 12
4.5 Major Products and Services 13
4.5.1 Overview 13
5 History 14
6 Competitors 16
7 Competitive Landscape 17
7.1 Nephrology and Urology Devices (Renal Dialysis Equipment), Global, Market Share (%), 2011 17
7.2 NxStage Medical, Inc., Nephrology and Urology Devices (Category), by Region, Market Share (2011) 19
7.3 NxStage Medical, Inc., Nephrology and Urology Devices (Category), by Country, Market Share (2011) 20
8 Key Employees 22
9 Key Employee Biographies 23
10 Company Statement 24
11 Locations And Subsidiaries 27
11.1 Head Office 27
11.2 Other Locations & Subsidiaries 27
12 Financial Deals Landscape 28
12.1 NxStage Medical, Inc., Deals Volume Summary, 2007 to YTD 2013 28
13 NxStage Medical, Inc., Deals Summary By Region, 2007 to YTD 2013 29
14 NxStage Medical, Inc. Detailed Deal Summary 31
14.1 Partnerships 31
14.1.1 Asahi Kasei Kuraray Medical Enters Into Licensing Agreement With NxStage Medical 31
14.1.2 NxStage Medical Enters Into Distribution Agreement With Dirinco 32
14.1.3 Medisystems Extends Supply And Distribution Agreement With Fenwal 33
14.1.4 Medisystems Enters Into An Agreement With Gambro 34
14.1.5 NxStage Medical Signs An Agreement With Kimal 35
14.1.6 NxStage Medical and DaVita Enter Into An Agreement For Home Hemodialysis 36
14.2 Equity Offering 37
14.2.1 NxStage Medical Completes Public Offering Of Common Stock For $66.1 Million 37
14.2.2 NxStage Medical Completes Private Placement Of $43 Million 38
14.2.3 NxStage Completes Private Placement Of $20 Million 39
14.3 Acquisition 40
14.3.1 NxStage Medical Acquires Medisystems 40
15 Recent Developments 41
15.1 Strategy And Business Planning 41
15.1.1 Oct 16, 2012: NxStage Opens New Headquarters In Lawrence, Massachusetts 41
15.1.2 Jun 17, 2009: NxStage Signs Distribution Agreement With Gambro 41
15.2 Financial Announcements 42
15.2.1 Nov 08, 2012: NxStage Reports Revenue Of $61.12m In Q3 2012 42
15.2.2 Aug 08, 2012: NxStage Reports Revenue Of $59m In Q2 2012 42
15.2.3 May 08, 2012: NxStage Reports Revenue Of $57m In Q1 2012 43
15.2.4 Feb 29, 2012: NxStage Reports Revenue Of $217.3m In 2011 44
15.2.5 Nov 03, 2011: NxStage Reports Revenues Of $559m In Q3 2011 45
15.2.6 Aug 03, 2011: NxStage Reports Revenues Of $53.8m In Q2 2011 46
15.2.7 May 04, 2011: NxStage Reports Revenues Of $50.6m In Q1 2011 46
15.2.8 Feb 17, 2011: NxStage Reports Revenues Of $179.2m In 2010 47
15.2.9 Nov 04, 2010: NxStage Reports Revenues Of $45m In Q3 2010 48
15.2.10 Jul 23, 2010: NxStage Reports Revenues Of $44m In Q2 2010 48
15.2.11 May 05, 2010: NxStage Reports Revenues Of $40.4 Million In Q1 2010 49
15.2.12 Feb 25, 2010: NxStage Reports Revenue Of $148.7 Million In 2009 49
15.2.13 Nov 05, 2009: NxStage Reports Net Revenue Of $38 Million In Q3 2009 50
15.2.14 Aug 05, 2009: NxStage Reports Revenues Of $36.4 Million In Q2 2009 51
15.2.15 May 08, 2009: NxStage Posts Net Loss Of $12.2 Million In Q1 2009 52
15.2.16 Mar 12, 2009: NxStage Reports 2008 Results 53
15.2.17 Feb 03, 2009: NxStage To Report 2008 Results 54
15.2.18 Nov 03, 2008: NxStage Reports 3Q 2008 Results 54
15.2.19 Aug 05, 2008: NxStage Reports 2Q 2008 Results 56
15.2.20 May 12, 2008: NxStage Reports Q1 2008 Results 57
15.2.21 Feb 12, 2008: NxStage Reports Q4 2007 Results 58
15.2.22 Nov 02, 2007: NxStage Reports Q3 2007 Results 60
15.2.23 Aug 02, 2007: NxStage Reports Q2 2007 Results 60
15.2.24 May 08, 2007: NxStage Reports Q1 2007 Results 61
15.2.25 Feb 15, 2007: NxStage Reports Q4 2006 Results 62
15.3 Corporate Communications 63
15.3.1 Jul 12, 2011: NxStage Medical Appoints Barry Straube To Board 63
15.3.2 Apr 27, 2011: NxStage Medical Appoints Michael Miller As President, International 63
15.3.3 Jan 24, 2011: NxStage Appoints Nancy Ham To Board And Announces Resignation Of Board Member Jonathan Silverstein 64
15.3.4 Dec 20, 2010: NxStage Promotes Joseph Turk As President, North America 64
15.3.5 Feb 23, 2010: NxStage Appoints Elise A. Tordella As VP And General Manager 65
15.3.6 Jan 19, 2010: NxStage Appoints John Mullen As Vice President And General Manager, International 65
15.3.7 Oct 28, 2008: NxStage Announces Board Changes 66
15.3.8 Jul 24, 2008: NxStage Appoints New Board Member 66
15.3.9 Mar 31, 2008: NxStage Appoints Senior Vice President, Manufacturing Operations 67
15.3.10 Feb 28, 2008: NxStage Appoints CCMA 67
15.4 Government and Public Interest 68
15.4.1 May 09, 2011: NxStage Supports Initiative By Patient Advocacy Groups To Educate Policymakers About Benefits Of Frequent Home Hemodialysis 68
15.4.2 Nov 22, 2010: Landmark Study In New England Journal Of Medicine Documents Significant Clinical Advantages Of More Frequent Hemodialysis: NxStage 68
15.5 Product News 69
15.5.1 May 24, 2012: NxStage Medical Announces Latest Interim Results From FREEDOM Study Of NxStage System One 69
15.5.2 May 11, 2012: CDRG Study Shows NxStage Daily Home Hemodialysis Patients More Likely To Receive Kidney Transplant 70
15.5.3 Aug 15, 2011: NxStage Announces Seven Year Anniversary Of IU Health’s Home Hemodialysis Program And Patient Milestones 71
15.5.4 Aug 02, 2011: NxStage Patient Advocate Jim Smith Begins West Coast Home Hemodialysis Tour With NxStage System 71
15.5.5 Jun 13, 2011: NxStage Announces Successful Kidney Transplant With NxStage System One 72
15.5.6 May 04, 2011: NxStage Announces TGA Approval And Distribution Agreement In Australia And New Zealand For System One 73
15.5.7 Apr 28, 2011: CDRG Study Shows Daily Home Hemodialysis Therapy With NxStage System One Lowers Risk Of Mortality 73
15.5.8 Feb 21, 2011: Independent Study Reports 50% Smaller Carbon Footprint With NxStage System One Versus Standard In-Center Hemodialysis Machines: NxStage 74
15.5.9 Feb 20, 2011: NxStage Medical Announces Interim Results From Ongoing FREEDOM Study Of NxStage System One 75
15.5.10 Feb 17, 2011: NxStage Announces Over 5,000 Patients Using System One For Home Hemodialysis 76
15.5.11 Jan 10, 2011: NxStage Receives FDA Clearance For Therapeutic Plasma Exchange Cartridge For Use With NxStage System One In Clinical Environment 76
15.5.12 Mar 08, 2010: NxStage Unveils Interim Results Of FREEDOM Study For NxStage System One 77
15.5.13 Feb 03, 2010: NxStage Forms Alliance With Nordic For Distribution Of NxStage System One And PureFlow SL Dialysate Preparation System 78
15.5.14 Dec 15, 2009: Group Of NxStage Home Hemodialysis Patients Plans Conventional Caribbean Cruise Trip With NxStage System One 78
15.5.15 Oct 27, 2009: NxStage Presents The Interim Results From FREEDOM Study Of NxStage System One 79
15.5.16 Nov 05, 2008: NxStage To Present The Interim Results Of The FREEDOM Study At American Society Of Nephrology Meeting 80
15.5.17 Nov 03, 2008: NxStage Achieves Milestone With 3,000 End-Stage Renal Disease Patients Receiving Daily Home Hemodialysis Therapy 80
15.5.18 Oct 24, 2008: NxStage Medical Reports Positive Interim Quality Of Life Results From Landmark FREEDOM Study 80
15.6 Product Approvals 81
15.6.1 May 04, 2011: NxStage Announces TGA Approval And Distribution Agreement In Australia And New Zealand For System One 81
15.6.2 Jan 10, 2011: NxStage Receives FDA Clearance For Therapeutic Plasma Exchange Cartridge For Use With NxStage System One In Clinical Environment 81
15.7 Clinical Trials 82
15.7.1 May 24, 2012: NxStage Medical Announces Latest Interim Results From FREEDOM Study Of NxStage System One 82
15.7.2 May 11, 2012: CDRG Study Shows NxStage Daily Home Hemodialysis Patients More Likely To Receive Kidney Transplant 82
15.7.3 Apr 28, 2011: CDRG Study Shows Daily Home Hemodialysis Therapy With NxStage System One Lowers Risk Of Mortality 83
15.7.4 Feb 20, 2011: NxStage Medical Announces Interim Results From Ongoing FREEDOM Study Of NxStage System One 84
15.7.5 Mar 08, 2010: NxStage Unveils Interim Results Of FREEDOM Study For NxStage System One 85
15.7.6 Oct 27, 2009: NxStage Presents The Interim Results From FREEDOM Study Of NxStage System One 86
15.7.7 Nov 05, 2008: NxStage To Present The Interim Results Of The FREEDOM Study At American Society Of Nephrology Meeting 87
15.7.8 Oct 24, 2008: NxStage Medical Reports Positive Interim Quality Of Life Results From Landmark FREEDOM Study 87
15.8 Other Significant Developments 87
15.8.1 Jul 26, 2011: NxStage Signs Five-Year Agreement With Theradial For Distribution Of System One Home Hemodialysis System In France 87
15.8.2 Jun 27, 2011: NxStage Medical Signs Lease For New Headquarters 88
15.8.3 Nov 30, 2010: NxStage Medical’s Medisystems Division Signs Distribution Agreement With Metro Medical 88
15.8.4 Jul 19, 2010: NxStage Commercializes NxStage System One And Certain Of Company’s In-Center Products In Italy Through Spindial 88
15.8.5 Apr 12, 2010: NxStage Medical’s Medisystems Division Expands Supply Agreement With RAI 89
15.8.6 Sep 14, 2009: NxStage Medical Signs Three-Year Supply Agreement With Reliant Renal Care 90
15.8.7 Jul 21, 2009: NxStage Extends Medisystems Needle Supply And Distribution Agreement With Fenwal 90
15.8.8 Jun 17, 2009: NxStage Signs Five-Year Distribution Agreement With Gambro 91
15.8.9 Jun 01, 2009: NxStage Expands Supply Agreement With B. Braun To Include Streamline Technology 91
15.8.10 May 07, 2009: NxStage And Kimal Announce First International Distribution of NxStage’s Home Hemodialysis And Critical Care Systems 92
15.8.11 Feb 27, 2009: iSirona Signs Agreement With NxStage 92
15.8.12 Oct 21, 2008: NxStage Signs Product Supply Contract With RAI 93
15.8.13 Sep 04, 2008: NxStage Extends Supply Contract With DaVita To Supply Blood Tubing Sets 93
15.8.14 Jan 07, 2008: NxStage Signs Supply Agreement With DaVita 93
16 Appendix 94
16.1 Research Methodology 95
16.2 Secondary Research 95
16.3 Primary Research 95
16.4 Models 96
16.5 Forecasts 96
16.6 Expert Panels 96
16.7 GlobalData Consulting 96
16.8 Currency Conversion 97
16.9 Contact Us 98
16.10 Disclaimer 98


【レポート販売概要】

■ タイトル:NxStage Medical, Inc.:市場シェア分析
■ 英文:NxStage Medical, Inc. Market Share Analysis
■ 発行日:2013年1月25日
■ 調査会社:GlobalData
■ 商品コード:GDATA403160147
■ 調査対象地域:グローバル
  • バルブ及びマニホールドの世界市場2015-2019
    About Valves and Manifolds Instrumentation valves are devices widely used in industrial production processes to control the flow of fluids and gases. These valves can be controlled either physically or automatically. There are different types of valves according to the needs and demands of the production process. Industries worldwide are increasingly using valves because they enhance production ef …
  • 医薬品製造委託の世界市場2016-2026
    Contract drug production – discover trends and markets with highest revenue potentialsWhere is outsourced pharma manufacturing heading? Visiongain’s updated study predicts that industry’s revenues from 2016. There you find potentials for sales growth, also exploring trends, technologies, clients’ needs and opportunities. That new report gives you revenue forecasts to 2026 at overall world market, …
  • 太陽電池の世界市場2016-2020:リチウムイオン電池、鉛蓄電池、ナトリウム系電池
    About Solar BatteriesBatteries generally refer to the technologies that are used for energy storage, which can be utilized later during power shortages, blackouts or during peak demand. These technologies mainly include pumped-hydro storage systems, advanced batteries, flywheels, and other evolving technologies. Solar batteries with solar PV systems can be connected to the grid or can be off-grid. …
  • 慢性血栓塞栓性肺高血圧症(CTEPH):治療薬のグローバル治験動向(2014年下半期)
    Chronic Thromboembolic Pulmonary Hypertension Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Chronic Thromboembolic Pulmonary Hypertension Global Clinical Trials Review, H2, 2014" provides data on the Chronic Thromboembolic Pulmonary Hypertension clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Chr …
  • 内視鏡検査システムの世界市場:予測とディスカッション2016-2026
    Endoscopy for Medicine: Why You Cannot Afford to Overlook that Rising Market – Introducing Your Guide to its Sales Potential What is the future of endoscopic devices and their producers? Visiongain’s new report gives you that data and analysis, helping you explore developments, technology and revenue predictions for endoscopic applications in healthcare. Discover where that industry heads. Our inv …
  • 世界の電力供給業界分析:Analyzing Electrical Supply Industries Worldwide
    Electric power transmission is the bulk transfer of electrical power (or more correctly energy), a process in the delivery of electricity to consumers. A power transmission network typically connects power plants to multiple substations near a populated area. The wiring from substations to customers is referred to as Electricity distribution, following the historic business model separating the wh …
  • 2014年戦略提言:日本の腸疾患診断検査市場
    About This ReportThis new 322-page report from Venture Planning Group presents detailed analysis of the Japanese Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia.  The report provides test volume and sales projections for Hospitals and Commercial/Pri …
  • カロテノイドの世界市場:βカロテン、ルテイン、ゼアキサンチン、アスタキサンチン
    About Carotenoids Carotenoids are a class of phytonutrients found in the cells of a wide variety of plants, bacteria, and algae, which help plants absorb light energy for the process of photosynthesis. They play an important antioxidant function of deactivating free radicals (single oxygen atoms that can damage cells by reacting with other molecules). Carotenoids are responsible for the bright red …
  • セルフストレージ(トランクルーム)ソフトウェアの世界市場2016-2020
    About the Self-Storage Software Market Self-storage refers to a system of renting out storage space like private rooms, box storage, lockers, vehicle storage, or any other space unit to individuals or businesses, usually on a short-term basis. Self-storage software is used by storage owners and tenants for managing operations in the self-storage industry. A large percentage of end-users use self-s …
  • Eスポーツの世界市場
    ABSTRACTAbout e-Sports The popularity of e-sports is increasing with the rising number of viewers. E-sports create an environment where viewers can experience playing the game. E-sports on a large scale is considered to be one of the most popular sports entertainment events in the world. On the global scenario, e-sports is a rapidly growing market and is likely to grow at a CAGR of 32.28%. In 2016 …
  • 学習管理システム(LMS)の世界市場2015-2022
    According to Stratistics MRC, the global learning management system market is expected to grow from $4.27 billion in 2015 to $17.08 billion by 2022 at a CAGR of 21.9%. The factors that are favoring the market growth are growing adoption of digital learning, improved collaboration between trainers and learners. Additionally, learning management system provides flexible and continuous learning platf …
  • エボラウイルスワクチンの世界市場機会分析
    Ebola virus is a member of the Filoviridae family, which can cause a zoonotic disease in humans. The virus can be transmitted between humans via contact with infected body fluids or large droplets of infected fluids, causing a sudden disease with flu-like symptoms, digestive disorders and hemorrhaging. The mean case fatality of historical outbreaks is around 65%. Most Ebola outbreaks occur in cent …
  • 堅牢デバイスの世界市場2016-2020
    About Rugged DeviceRugged devices were first used by the military. Therefore, in 1962, the US Department of Defense published its military standard for rugged devices — MIL-STD-810 — regarding environmental effects on equipment. The commercial and industrial segments also started to incorporate rugged devices with the increasing benefits of using them. Therefore, the ruggedness levels have been br …
  • グローバル電力産業におけるM&A及び投資動向:2014年1月
    Power Monthly Deal Analysis - January 2014: M&A and Investment Trends Summary GlobalData's “Power Monthly Deal Analysis - January 2014: M&A and Investment Trends” report is an essential source of data and trend analysis on the mergers and acquisitions (M&As) and financings in the power industry. The report provides detailed information on M&As, equity/debt offerings, private equity, venture financ …
  • 世界のジオシンセティックス市場動向(2012-2016)
    TechNavio's analysts forecast the Global Geosynthetics market to grow at a CAGR of 8.68 percent over the period 2012-2016. One of the key factors contributing to this market growth is the growth of the Construction industry in developing countries. The Global Geosynthetics market has also been witnessing the increased use of geosynthetics in road construction. However, the lack of awareness of the …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。